December 30, 2020
You can have a role in research that could change medicine forever.
Paid clinical research studies are being conducted at Heart Lung Centre to learn more about investigational medications that are not yet available to the public.
Are Clinical Trials safe?
This is a very important question. At Heart Lung Centre, all our trials are reviewed by an independent Research Ethics Committee, who ensure that our trials are as safe as possible. We are here to answer any questions.
Learn More
Do I get paid?
Our trials vary greatly in terms of time spent on the unit and the number of procedures performed. Once we have identified a suitable trial, we can inform you of the potential compensation for your participation.
Learn More
What facilities are there?
Whether you’re here for an hour or the whole day, we will endeavour to make your stay as comfortable as possible. The volunteer lounge will provide you with a space to pass the time pleasantly between assessments.
Why do you offer Clinical Trials?
Before a medication or new device for treatment of medical issues is available to the public, the Food and Drug Administration (FDA) must review and approve the medication or device for public use. The FDA does this to learn more about the product and make sure that it is effective and safe.
To get FDA approval, the company that makes the medication or device is required to conduct clinical research studies.
The companies ask people to volunteer for clinical research studies. In these studies, volunteers are given the investigational medication or device and are evaluated by study doctors and staff members.
After clinical research studies are completed, the pharmaceutical company submits the study information to the FDA. The FDA reviews this information and decides if the investigational medication or device can become available to the public.
-
Asthma studies
Asthma Clinical Trials are to evaluate newly developed medications and new combinations of well-established medications for the treatment of asthma.
For all studies, participants are paid for their time, travel and any inconvenience.
Medications administered, trial or placebo would be in addition to a volunteer’s current medication(s).
If you would like to find out more register your interest and we will be in touch. Or contact us on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Current studies are detailed below.
-
Asthma Study D9181C0001
This is a clinical trial to evaluate a newly developed medication for the treatment of Asthma against a placebo. The medication has been tested in previous clinical trials with volunteers and no safety concerns were raised.
Any medication administered, trial or placebo would be in addition to your current medication(s)
To take part in this study you:
- Must have been diagnosed with Asthma for 12 months or more
- Must be between the ages of 18 to 65
- Must use Preventative Asthma Medication on a stable, daily basis to manage your Asthma
- Must be a non-smoker or an ex-smoker
- Must Not be, pregnant, lactating or trying to conceive with your partner. (If applicable)
- Must Not be currently enrolled another Clinical Trial
This study involves up to 13 visits to our Central London Clinic over 5.5 to 6 months. No over-night stays required.
You will be paid up to £1500 pro rata for your time, and any inconvenience (£125 per visit). Travel expenses are included.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.
REGISTER -
Asthma Study D3250C00059
This is a clinical trial to evaluate a newly developed anti-inflammatory medication for the treatment of Asthma against a placebo. The medication has been tested in previous clinical trials with volunteers with severe Asthma, no safety issues were reported and the medication was shown to significantly reduce exacerbation rates, improve lung function and symptoms.
Any medication administered, trial or placebo would be in addition to your current medication(s).
To take part in this study you:
- Must have been diagnosed with Asthma for 12 months or more
- Must be between the ages of 18 to 70
- Must use preventative Asthma medication on a stable, daily basis to manage your Asthma
- Must be a non-smoker or an ex-smoker
- Must Not be, pregnant, lactating or trying to conceive with your partner. (If applicable)
- Must Not be currently enrolled another Clinical Trial
This study involves 11 to 13 visits to our central London clinic over 58 weeks. No over-night stays required.
You will be paid up to £1650 (pro rata) for your time, and any inconvenience. Reasonable travel expenses will be reimbursed.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.
REGISTER -
Asthma Study D9183.000000_MED13506
This is a clinical trial to evaluate a newly developed medication for the treatment of Asthma against a placebo. The medication ‘MED13506’ has been tested in previous clinical trials with volunteers and no safety issue were reported.
Any medication administered, trial or placebo would be in addition to your current medication(s).
To take part in this study you:
- Must have been diagnosed with Asthma before the age of 25.
- Must be using a preventative Asthma medication on a stable, daily basis to manage your Asthma
- Must be aged between 18 to 65.
- Must be a Non-Smoker or an Ex-Smoker.
- Must Not be currently enrolled in another clinical trial.
- Must Not be pregnant, lactating or trying to conceive with your partner. (If applicable)
This study involves up to 13 visits to our central London clinic over approximately 5 ½ to 6 months. No over-night stays would be required.
You will be paid £1500 for your time, travel, and any inconvenience. (£125 per visit, travel included).
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.
REGISTER
-
COPD studies
Chronic Obstructive Pulmonary Disease Clinical Trials are to evaluate newly developed medications and new combinations of well-established medications for the treatment of COPD.
For all studies, participants are paid for their time, travel and any inconvenience.
Medications administered, trial or placebo would be in addition to a volunteer’s current medication(s).
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Current studies are detailed below.
-
COPD Study GSK - 2018N357924
This is a clinical trial to evaluate a newly developed medication for the treatment of COPD against a placebo. The medication ‘Mepolizumab’ has been tested in previous clinical trials with volunteers and no safety issue were reported.
Any medication administered, trial or placebo would be in addition to your current medication(s).
To take part in this study you:
- Must have been diagnosed with Chronic Obstructive Pulmonary Disease / COPD for 12 months or more.
- Must be aged 40 and above.
- Must be a Smoker or an Ex-Smoker.
- Must be using Inhaler(s) to manage your COPD.
- Must have a history of COPD exacerbation(s) within the last 12 months.
- Must Not be currently enrolled in another clinical trial.
This study involves 16 to 17 short visits to our central London clinic over 58 weeks. No over-night stays required.
You will be paid £30 per visit for your time (£480 – £510 pro rata), and any inconvenience. Reasonable travel expenses will be reimbursed.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.
REGISTER -
COPD Study CLI – 06001AA1 – 04_05
This is a clinical trial to evaluate a newly developed medication for the treatment of COPD - Chronic Obstructive Pulmonary Disease against a placebo. The CHF6001 Medication has been tested in previous trials with COPD volunteers. No safety issues have been reported in these studies and the medication has been well tolerated.
Any medication administered, trial or placebo would be in addition to your current medications.
To take part in this study you:
- Must have been diagnosed with COPD for 12 months or more.
- Must be aged 40 and above.
- Must be a Smoker or an Ex-Smoker.
- Must be using Inhaler(s) to manage your COPD.
- Must have a history of COPD exacerbation(s) within the last 12 months.
- Must Not be currently enrolled in another clinical trial.
This study involves 6 to 7 short visits to our Central London clinic over 52 weeks. No over-night stays are required.
You will be paid up to £1000, pro rata for your time, and any inconvenience. Reasonable travel expenses will be reimbursed.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.
REGISTER -
COPD Study RPL554-CO-301_24
This is a 24-week clinical trial to evaluate a newly developed medication for the treatment of COPD against a placebo. The medication ‘Ensifentrine’ has been tested in previous clinical trials with volunteers and no safety issue were reported.
Any medication administered, trial or placebo would be in addition to your current medication(s).
To take part in this study you:
- Must have been diagnosed with Chronic Obstructive Pulmonary Disease / COPD for 12 months or more.
- Must be aged between 40 to 80.
- Must be a Smoker or an Ex-Smoker.
- Must Not be currently enrolled in another clinical trial.
This study involves up to 5 visits to our central London clinic over 24 weeks. No over-night stays required.
You will be paid £1250 pro rata for your time and any inconvenience. Reasonable travel expenses will be reimbursed.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.
REGISTER
-
Alopecia studies
Alopecia Clinical Trials are to evaluate new medications and new combinations of well-established medications for the treatment of Alopecia.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Current studies are detailed below.
-
SOTO1- 2021-004145-20
This is a clinical trial to assess the efficiency and safety of a range of doses of a controlled release formulation of dithranol for the treatment of mild to moderate patchy alopecia areata.
The medication is licensed and widely used for the treatment of psoriasis (e.g., Dithrocream) and listed as a 'special' by the British Association of Dermatologists for use in AA (Messenger et al, 2012) Dithranol has a well-known safety profile with no history of serious adverse events.
To take part in this study you:
- Must have Active Alopecia Areata present for at least 6 months.
- Must Not have any other types of alopecia or any other hair loss disorders
- Must Not be using any topical hair loss treatment currently
- Must Not be, pregnant, lactating or trying to conceive with your partner. (If applicable)
- Must Not be currently enrolled another Clinical Trial
This study involves up to 9 visits to our Central London Clinic over 8.5 to 9 months. All visits may last between 2 to 3 hours.
Reasonable Travel expenses will be reimbursed.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
REGISTER
-
Erectile Dysfunction studies
Erectile Dysfunction Clinical Trials are to evaluate new medications and new combinations of well-established medications for the treatment of Erectile Dysfunction.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
Current studies are detailed below.
-
RestoriT-001
This is a clinical trial to determine the effect of Invicorp 25mcg/2mg on Erectile Dysfunction post radical prostatectomy.
This medication is an approved treatment for erectile dysfunction after failure of oral drugs.
To take part in this study you:
- Must have been diagnosed with Prostate Cancer.
- Must be scheduled for radical prostatectomy? (Either nerve sparing or non-nerve sparing)
- Must be happy to administer the study drug at home.
- Must Not be currently enrolled another Clinical Trial.
This study involves up to 6 visits to our Central London Clinic over 5.5 to 6 months. All visits may last between 2 to 4 hours.
Reasonable Travel expenses will be reimbursed.
If you believe you may be eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com
REGISTER
FAQ'S
If you want to know more about clinical trials or are considering participating in one, the following frequently asked questions describe the role of a patient and will help you understand this unique research program.
FAQ'S-
CLINICAL TRIALS, FAQ'S -
CLINICAL TRIALS, FAQ'S 
December 30, 2020Are the clinical trials safe?
-
CLINICAL TRIALS, FAQ'S 
December 30, 2020Can I take part?
-
CLINICAL TRIALS, FAQ'S 
December 30, 2020Can I choose which study I take part in?
-
CLINICAL TRIALS, FAQ'S 
December 30, 2020How much do the trials pay?
-
CLINICAL TRIALS, COVID TESTS, FAQ'S 
December 30, 2020How do I contact you?
Location
Explore beyond the Heart Lung Centre and discover Respiratory Clinical Trials and our hospital Queen Anne Street Medical Centre. Our state of the art facility offers a range of medical services, including consultants in different specialties, diagnostic tests and an operating theatre.
13-14 Fitzroy Square,
London, W1T 6AH
E: recruitment@heartlungcentre.com
P: 0800 023 4824
P: 0207 0343341
Give us a call or email us, we endeavour to answer all enquiries within 24 hours on business days.
We are open from 8am — 5pm week days.